Yu H Z, Zeng W Z, Wu W Y, Yao Z Q, Feng Y
Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China.
Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Aug 18;54(4):705-711. doi: 10.19723/j.issn.1671-167X.2022.04.020.
To explore the effect of hypothyroidism (HT) on the ocular surface status of patients with primary Sjögren's syndrome-related dry eye (pSS-DED).
The cross-sectional study included 36 patients with pSS-DED who were treated at the dry eye clinic of Peking University Third Hospital from December 2020 to June 2021, of whom 12 were pSS-DED patients combined with HT. In the same period, 24 patients with simple dry eye disease (DED) were served as a control group. All the patients filled out the Ocular Surface Disease Index (OSDI) questionnaire, and performed tear film break-up time (BUT), Schirmer test, tear meniscus height, corneal/conjunctival fluorescein staining, meibomian gland secretion capacity, meibum evaluation and confocal microscope examination.
(1) Compared with pSS-DED and simple DED patients, pSS-DED +HT patients had lower average BUT [(2.7±0.8) s], Schirmer test [(4.9±4.8) mm] and tear meniscus height [(0.13±0.03) mm], and the difference was statistically significant (=12.43, < 0.01; =6.96, < 0.01; =3.31, < 0.05). (2) Compared with DED and pSS-DED patients, the meibomian gland secretion capacity and meibomian trait scores of pSS-DED+HT patients were mainly distributed in the high division. There were statistically significant differences in the distribution of secretion capacity of meibomian glands (=10.72, < 0.05) and meibomian trait assessment scores (=8.34, < 0.05) among the three groups. (3) Serum total thyroxine and serum free thyroxine levels in the pSS-DED+HT patients showed positive correlation ( < 0.05, < 0.05) with their BUT (=0.60, 0.60), Schirmer's test (=0.64, 0.66) and tear river height (=0.61, 0.62), independent of lid gland secretory capacity; no significant correlation was found between thyroid-stimulating hormone, anti-thyroglobulin antibody and lid gland secretory capacity. Thyroid hormone, anti-thyroglobulin antibody, and thyroid peroxidase antibody were not found to be significantly correlated with ocular surface status. (4) Compared with pSS-DED, the fiber density of the subbasal nerve plexus in pSS-DED+HT group decreased (=2.06, < 0.05), and the curvature score increased (=2.13, < 0.05).
The ocular surface condition of pSS-DED patients with HT is worse than that of pSS-DED and DED patients. The main manifestations are that tear secretion, tear film stability, secretory function of the meibomian glands, meibum trait and fiber density of the subbasal nerve plexus decrease while the curvature increases. The mechanism might be related to the decrease in thyroid hormone production.
探讨甲状腺功能减退症(HT)对原发性干燥综合征相关干眼(pSS-DED)患者眼表状况的影响。
本横断面研究纳入了2020年12月至2021年6月在北京大学第三医院干眼门诊接受治疗的36例pSS-DED患者,其中12例为pSS-DED合并HT患者。同期,将24例单纯干眼(DED)患者作为对照组。所有患者均填写眼表疾病指数(OSDI)问卷,并进行泪膜破裂时间(BUT)、泪液分泌试验、泪河高度、角膜/结膜荧光素染色、睑板腺分泌能力、睑脂评估及共聚焦显微镜检查。
(1)与pSS-DED患者和单纯DED患者相比,pSS-DED +HT患者的平均BUT[(2.7±0.8)秒]、泪液分泌试验[(4.9±4.8)毫米]和泪河高度[(0.13±0.03)毫米]更低,差异具有统计学意义(F=12.43,P<0.01;F=6.96,P<0.01;F=3.31,P<0.05)。(2)与DED患者和pSS-DED患者相比,pSS-DED+HT患者的睑板腺分泌能力和睑脂特征评分主要分布在高分段。三组间睑板腺分泌能力分布(F=10.72,P<0.05)和睑脂特征评估评分(F=8.34,P<0.05)存在统计学差异。(3)pSS-DED+HT患者的血清总甲状腺素和血清游离甲状腺素水平与其BUT(r=0.60,P=0.60)、泪液分泌试验(r=0.64,P=0.66)和泪河高度(r=0.61,P=0.62)呈正相关,且独立于睑板腺分泌能力;促甲状腺激素、抗甲状腺球蛋白抗体与睑板腺分泌能力之间未发现显著相关性。甲状腺激素、抗甲状腺球蛋白抗体和甲状腺过氧化物酶抗体与眼表状况未发现显著相关性。(4)与pSS-DED相比,pSS-DED+HT组基底神经丛下层的纤维密度降低(t=2.06,P<0.05),弯曲度评分增加(t=2.13,P<0.05)。
合并HT的pSS-DED患者的眼表状况比pSS-DED患者和DED患者更差。主要表现为泪液分泌、泪膜稳定性、睑板腺分泌功能、睑脂特征及基底神经丛下层纤维密度降低,而弯曲度增加。其机制可能与甲状腺激素分泌减少有关。